Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach

Christos F Fotis; Nikolaos Meimetis; Nikos Tsolakos; Marianna Politou; Karolina Akinosoglou; Vicky Pliaka; Angeliki Minia; Evangelos Terpos; Ioannis P. Trougakos; Andreas Mentis; Markos Marangos; George Panayiotakopoulos; Meletios A. Dimopoulos; Charalampos Gogos; Alexandros Spyridonidis; Leonidas G. Alexopoulos

doi:10.1101/2020.09.09.20191122

Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach

Christos F Fotis, Nikolaos Meimetis, Nikos Tsolakos, Marianna Politou, Karolina Akinosoglou, Vicky Pliaka, Angeliki Minia, Evangelos Terpos, Ioannis P. Trougakos, Andreas Mentis, Markos Marangos, George Panayiotakopoulos, Meletios A. Dimopoulos, Charalampos Gogos, View ORCID ProfileAlexandros Spyridonidis, Leonidas G. Alexopoulos

doi: https://doi.org/10.1101/2020.09.09.20191122

Christos F Fotis

1 Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: chfoti@gmail.com

Nikolaos Meimetis

1 Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: nmeimetis97@gmail.com

Nikos Tsolakos

2 ProtATonce Ltd;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: nikos.tsolakos@protatonce.com

Marianna Politou

3 Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mariannapolitou@gmail.com

Karolina Akinosoglou

4 Department of Internal Medicine, Division of Infectious Diseases, University Hospital of Patras, Patras, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: akin@upatras.gr

Vicky Pliaka

5 ProtATonce Ltd,;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: vicky.pliaka@protatonce.com

Angeliki Minia

2 ProtATonce Ltd;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: angeliki.minia@protatonce.com

Evangelos Terpos

3 Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: eterpos@med.uoa.gr

Ioannis P. Trougakos

6 Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: itrougakos@biol.uoa.gr

Andreas Mentis

7 Medicinal Microbiology Laboratory, Hellenic Pasteur Institute, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mentis@pasteur.gr

Markos Marangos

4 Department of Internal Medicine, Division of Infectious Diseases, University Hospital of Patras, Patras, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mmarangos@yahoo.com

George Panayiotakopoulos

8 Pharmacology Laboratory, University of Patras, Patras, Greece & National Public Health Organization, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gpanayiotakopoulos@hotmail.com

Meletios A. Dimopoulos

3 Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mdimop@med.uoa.gr

Charalampos Gogos

4 Department of Internal Medicine, Division of Infectious Diseases, University Hospital of Patras, Patras, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: cgogos@med.upatras.gr

Alexandros Spyridonidis

9 Department of Internal Medicine, BMT Unit and CBMDP Donor Center, University of Patras, Patras, Greece;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alexandros Spyridonidis
For correspondence: spyridonidis@upatras.gr

Leonidas G. Alexopoulos

10 Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece & ProtATonce Ltd, Demokritos Science Park, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: leo@mail.ntua.gr

Abstract
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Article usage

Article usage: September 2020 to January 2021

	Abstract	Pdf
Sep 2020	468	153
Oct 2020	301	92
Nov 2020	141	58
Dec 2020	96	42
Jan 2021	87	30

View the discussion thread.

PreviousNext

Posted September 10, 2020.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach

medRxiv 2020.09.09.20191122; doi: https://doi.org/10.1101/2020.09.09.20191122

Share This Article:

Citation Tools

Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach

medRxiv 2020.09.09.20191122; doi: https://doi.org/10.1101/2020.09.09.20191122

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Public and Global Health

Subject Areas

All Articles

Addiction Medicine (62)
Allergy and Immunology (142)
Anesthesia (47)
Cardiovascular Medicine (416)
Dentistry and Oral Medicine (70)
Dermatology (49)
Emergency Medicine (146)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
Epidemiology (4875)
Forensic Medicine (3)
Gastroenterology (183)
Genetic and Genomic Medicine (678)
Geriatric Medicine (70)
Health Economics (192)
Health Informatics (633)
Health Policy (322)
Health Systems and Quality Improvement (208)
Hematology (85)
HIV/AIDS (156)
Infectious Diseases (except HIV/AIDS) (5362)
Intensive Care and Critical Care Medicine (332)
Medical Education (94)
Medical Ethics (24)
Nephrology (75)
Neurology (690)
Nursing (42)
Nutrition (115)
Obstetrics and Gynecology (127)
Occupational and Environmental Health (209)
Oncology (443)
Ophthalmology (140)
Orthopedics (36)
Otolaryngology (90)
Pain Medicine (35)
Palliative Medicine (17)
Pathology (130)
Pediatrics (196)
Pharmacology and Therapeutics (131)
Primary Care Research (84)
Psychiatry and Clinical Psychology (782)
Public and Global Health (1823)
Radiology and Imaging (325)
Rehabilitation Medicine and Physical Therapy (138)
Respiratory Medicine (255)
Rheumatology (86)
Sexual and Reproductive Health (69)
Sports Medicine (62)
Surgery (102)
Toxicology (23)
Transplantation (29)
Urology (37)